MyFinsight
Home
Blog
About
Contact
Download
Download image
In-process research and
development, net of...
$71,106,250
Deferred financing costs
$169,252
Inventory
$22,659,590
Prepaid expenses
$3,052,387
Cash and cash
equivalents
$2,632,634
Accounts receivable, net
of allowances
$1,079,055
Total other assets
$71,275,502
Total current assets
$29,423,666
Total assets
$100,699,168
Total liabilities and
stockholders equity
$100,699,168
Total liabilities
$65,430,399
Total stockholders
equity
$35,268,769
Accumulated deficit
-$96,183,720
Total current
liabilities
$58,812,298
Note payable to
related party
$3,800,111
Deferred tax liability
$2,817,990
Additional paid-in capital
$131,443,191
Common stock - 0.0001
par value...
$9,298
Accrued expenses
$24,057,573
License payable
$17,650,000
Accounts payable
$8,883,239
Due to related party
$8,221,486
Back
Back
Balance Sheet
CITIUS ONCOLOGY, INC. (CTOR)
CITIUS ONCOLOGY, INC. (CTOR)
source: myfinsight.com